Bilaketaren emaitzak - Garg, Vishvas

Noninsulin pharmacological management of type 1 diabetes mellitus nork Garg, Vishvas

Testu osoa Testu osoa Testu osoa

Health economic evaluation of dipeptidyl peptidase-4 inhibitors nork Garg, Vishvas

Testu osoa Testu osoa Testu osoa

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patie... nork Aletaha, Daniel, Snedecor, Sonya J, Ektare, Varun, Xue, Mei, Bao, Yanjun, Garg, Vishvas

Testu osoa Testu osoa Testu osoa

Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review nork Liu, Yifei, Yang, Min, Garg, Vishvas, Wu, Eric Q., Wang, Jessie, Skup, Martha

Testu osoa Testu osoa Testu osoa

Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study nork Aletaha, Daniel, Epstein, Andrew J., Skup, Martha, Zueger, Patrick, Garg, Vishvas, Panaccione, Remo

Testu osoa Testu osoa Testu osoa

A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis nork Edwards, Christopher J., Sawant, Ruta, Garg, Vishvas, Du, Ella X., Friedman, Alan, Betts, Keith A.

Testu osoa Testu osoa Testu osoa

Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry nork Pappas, Dimitrios A., Kremer, Joel M., Griffith, Jenny, Reed, George, Salim, Bob, Karki, Chitra, Garg, Vishvas

Testu osoa Testu osoa Testu osoa

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study nork Van den Bosch, Filip, Ostor, Andrew J. K., Wassenberg, Siegfried, Chen, Naijun, Wang, Chen, Garg, Vishvas, Kalabic, Jasmina

Testu osoa Testu osoa Testu osoa

Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study nork Van den Bosch, Filip, Ostor, Andrew J. K., Wassenberg, Siegfried, Chen, Naijun, Wang, Chen, Garg, Vishvas, Kalabic, Jasmina

Testu osoa Testu osoa Testu osoa

Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis nork Bergman, Martin, Saffore, Christopher D., Kim, Katherine J., Patel, Pankaj A., Garg, Vishvas, Xuan, Si, Naik, Haley B.

Testu osoa Testu osoa Testu osoa

Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From... nork Kaeley, Gurjit S., MacCarter, Daryl K., Goyal, Janak R., Liu, Shufang, Chen, Kun, Griffith, Jennifer, Kupper, Hartmut, Garg, Vishvas, Kalabic, Jasmina

Testu osoa Testu osoa Testu osoa

Caveat Oncologist: Clinical Findings and Consequences of Distributing Counterfeit Erythropoietin in the United States nork Qureshi, Zaina P., Norris, LeAnn, Sartor, Oliver, McKoy, June M., Armstrong, John, Raisch, Dennis W., Garg, Vishvas, Stafkey-Mailey, Dana, Bennett, Charles Lee

Testu osoa Testu osoa Testu osoa

Life-threatening Dermatologic Adverse Events in Oncology nork Rosen, Alyx C., Balagula, Yevgeniy, Raisch, Dennis.W., Garg, Vishvas, Nardone, Beatrice, Larsen, Nicole, Sorrell, Jennifer, West, Dennis P., Anadkat, Milan J., Lacouture, Mario E.

Testu osoa Testu osoa Testu osoa

Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts: A Systematic Review from the Research... nork Edwards, Beatrice J., Bunta, Andrew D., Lane, Joseph, Odvina, Clarita, Rao, D. Sudhaker, Raisch, Dennis W., McKoy, June M., Omar, Imran, Belknap, Steven M., Garg, Vishvas, Hahr, Allison J., Samaras, Athena T., Fisher, Matthew J., West, Dennis P., Langman, Craig B., Stern, Paula H.

Testu osoa Testu osoa Testu osoa